Abstract
Recurrence and metastasis are associated with increased mortality and poor outcomes in early breast cancer (EBC) patients. To predict loco-regional recurrence or distant metastasis, various prediction models based on clinicopathological characteristics or genetic profiles have been suggested. However, most of those systems focused on the primary tumor, and prediction of recurrence in EBC is still limited. The sentinel lymph nodes (SLNs) are the first few lymph nodes into which a tumor drains and an important barrier for protecting against metastasis.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
